Nature Communications (Feb 2021)

Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome

  • Sabine A. Hartlieb,
  • Lina Sieverling,
  • Michal Nadler-Holly,
  • Matthias Ziehm,
  • Umut H. Toprak,
  • Carl Herrmann,
  • Naveed Ishaque,
  • Konstantin Okonechnikov,
  • Moritz Gartlgruber,
  • Young-Gyu Park,
  • Elisa Maria Wecht,
  • Larissa Savelyeva,
  • Kai-Oliver Henrich,
  • Carolina Rosswog,
  • Matthias Fischer,
  • Barbara Hero,
  • David T. W. Jones,
  • Elke Pfaff,
  • Olaf Witt,
  • Stefan M. Pfister,
  • Richard Volckmann,
  • Jan Koster,
  • Katharina Kiesel,
  • Karsten Rippe,
  • Sabine Taschner-Mandl,
  • Peter Ambros,
  • Benedikt Brors,
  • Matthias Selbach,
  • Lars Feuerbach,
  • Frank Westermann

DOI
https://doi.org/10.1038/s41467-021-21247-8
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 18

Abstract

Read online

Alternative lengthening of telomeres (ALT) is associated with a poor outcome in neuroblastoma. Here, the authors find that ALT is associated with mutated ATRX and/or reduced protein abundance, frequent telomeric repeat loci and heterochromatic telomeric chromatin.